Find Molecular Interactions in the Scientific Literature
This website is free and open to all users and there is no login requirement
Filter the results by organism
Add multiple IDs separated by commas
Filter the result by interaction type
Filter the result by minimal factuality of the interactions
Filter the result by keywords occurring in the context of interactions
Filter the result by keywords occurring in headings of sections and abstracts that contain interactions
Result Statistics
Result statistics
Number unique A-genes1
Number unique B-genes6
Number unique A-B gene pairs6
Total number of interactions1286
Top Interactions
A-argumentB-argumentcount
MTORAMPK1159
MTORPRKAA259
MTORPRKAA151
MTORPRKAB114
MTORPRKAB22
MTORPRKAG11
A-list mapping 1 0
inputrecognized symbolmapping type
mtorMTOROrthology Cluster
B-list mapping 1 0
inputrecognized symbolmapping type
ampkAMPKFamPlex Concept
Interaction Partner Distribution A-List (Pie)
Interaction Partner Distribution A-List (Bars)
Most Frequent Interactions
Interactions with Common Partners
Table View
Gene A SymbolGene B SymbolGene A Gene IDGene B Gene IDRelation TypesFactualityFulltext Match SourceDocument IDContext
MTOR PRKAA2 2475 5563 Regulation
   
none19679549
 Metformin, the most widely used drug in the treatment of type 2 diabetes, activates AMP kinase (AMPK), which negatively regulates mTOR.
MTOR AMPK 2475 FPLX:AMPK Regulation
   
none19679549
 Metformin, the most widely used drug in the treatment of type 2 diabetes, activates AMP kinase (AMPK), which negatively regulates mTOR.
MTOR PRKAA1 2475 5562 Negative_regulation, Positive_regulation
   
none25591762
 High glucose-induced extracellular matrix accumulation and mTOR activation were significantly inhibited by the co-treatment of rAAV-AMPKα1(312) (encoding constitutively active AMPKα1) whereas activated by r-AAV-AMPKα1D157A (encoding dominant negative AMPKα1).
MTOR AMPK 2475 FPLX:AMPK Regulation
   
none33714781
 Besides, metformin inhibits cystic fibrosis transmembrane conductance regulator (CFTR)-mediated fluids secretion and the mammalian target of rapamycin (mTOR)-involved cyst formation negatively regulated by AMPK in autosomal dominant polycystic kidney disease (APDKD).
MTOR AMPK 2475 FPLX:AMPK Negative_regulation
   
none32245619
 Humanin attenuates palmitate-induced hepatic lipid accumulation and insulin resistance via AMPK-mediated suppression of the mTOR pathway.
MTOR AMPK 2475 FPLX:AMPK Regulation
   
nonePMC4880882
 Metformin has been shown to alter AMPK, a protein kinase that directly and indirectly regulates mTOR signaling via phosphorylation of Raptor and TSC2, respectively.
MTOR AMPK 2475 FPLX:AMPK Positive_regulation
   
nonePMC8945547
 In hypopharyngeal cancer cells, p-mTOR was reduced through activation of ERK and AMPK signaling pathways by metformin, resulting in cell cycle arrest, apoptosis and autophagy triggering [].
MTOR AMPK 2475 FPLX:AMPK Positive_regulation
   
nonePMC5386770
 Interestingly, Jin et al. proposed that Twist1 depletion sensitized NSCLC cells to cisplatin by stimulating AMPK-induced mTOR inhibition and subsequent reduction in Mcl-1 protein [].
Mtor AMPK 56718 FPLX:AMPK Regulation
   
nonePMC9526660
 In addition, the mTOR is negatively regulated by AMPK, of which expression is up-regulated with suppressed autophagy.
MTOR AMPK 2475 FPLX:AMPK Negative_regulation, Positive_regulation
   
nonePMC6690605
 Moreover, it also enhanced the lumican expression transcriptionally, which indicated that hypoxia-induced mTOR activation was blocked by activated AMPK.